Electroconvulsive therapy
ProcedureElectroconvulsive therapy
NCT Number: NCT00069407
This study will compare the antidepressant benefits and cognitive side effects of three different types of electroconvulsive therapy (ECT) in people with unipolar or bipolar depression.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mayo Clinic, Rochester, Minnesota, United States
ECT is an important treatment for severely depressed people who do not respond adequately to, or are intolerant of, antidepressant medication. Traditionally, ECT has been administered with one of two standard techniques: bilateral and right unilateral electrode placement. However, these techniques are limited by either low efficacy or high cognitive impairment. Recently, an additional technique for ECT administration has shown promise in preliminary studies: bifrontal ECT. This study will compare this technique to the two traditional ECT techniques in treating people with depressive symptoms.
Participants in this study will be randomly assigned to receive standard bilateral ECT, high-dose right unilateral ECT, or bifrontal ECT in their index course. Depression symptoms, neuropsychological status, and quality of life will be measured throughout the course of the ECT treatment, one week after, and at a 2-month follow-up visit. This study will run for 4 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Electroconvulsive therapy
Time frame: 4 weeks
Depression symptom rating
Time frame: 4 weeks
neuropsychological test battery
University of Medicine and Dentistry of New Jersey
Other
Comparing Three Electrode Placements to Optimize ECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT04684615
Anxiety, Anxiety Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT05228964
Anxiety Disorders, Behavior
Austin, Texas, United States
View Trial DetailsNCT02220309
Anxiety, Anxiety Disorders
Los Altos, California, United States
View Trial Details